JPRN-UMIN000003903已完成1 期
Tumor specific vaccination therapy for advanced/recurrent cervical cancer using HLA-A*0201 restricted Specific Epitope Peptides Cocktail derived from Tumor genom/Tumor related Angiogenetic factors genom - Therapeutic vaccination therapy for cervical cancer
Iwate Medical University School of Medicine department of Obastetrics and Gynecology0 个研究点目标入组 30 人开始时间: 2010年7月12日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. pregnant women 2. breast feeding mothor(stop brest feeding) 3.women who are willing to be pregnant(must perform contraception) 4.complication of uncontrolable infection 5.Usage of continual systemic steroid and immuno-suppressant is prohibited during treatment. 6. Who are recognized ineligible by the resiponsible investigator or investigators
研究者
相似试验
已完成
1 期
Tumor specific vaccination therapy for advanced/recurrent ovarian cancer using HLA-A*0201 restricted Specific Epitope Peptides Cocktail derived from Tumor genom/Tumor related Angiogenetic factors genomadvanced/recurrent ovarian cancer with the conditions of unremoval by surgery, or refractory, chemo-resistant disease.JPRN-UMIN000003860Iwate Medical University School of Medicine Department of Obstetrics and Gynecology30
已完成
1 期
Tumor specific vaccination therapy for advanced/recurrent cervical cancer using HLA-A*2402 restricted Specific Epitope Peptides Cocktail derived from Tumor genom/Tumor related Angiogenetic factors genomJPRN-UMIN000003902Iwate Medical University School of Medicine department of Obstetrics and Gynecology30
已完成
1 期
Tumor specific vaccination therapy for advanced/recurrent ovarian cancer using HLA-A*2402 restricted Specific Epitope Peptides Cocktail derived from Tumor genom/Tumor related Angiogenetic factors genomadvanced/recurrent ovarian cancer with the conditions of unremoval by surgery, or refractory, chemo-resistant disease.JPRN-UMIN000003862Iwate Medical University School of Medicine department of obstetrics and gynecology30
未知
1 期
Cancer vaccination therapy by using tumor-associated antigen GPC3-targeted peptide in the partients who have received trans-arterial infusion chemotherapy against advanced hepatocellular carcinoma -A randomized double blind studyhepatocellular carcinomaJPRN-UMIN000001732Department of Gastroenterology and Hepatology, Graduate School of Medical Sciences Kumamoto University20
招募中
2 期
Adjuvant treatment of novel multiple cancer vaccine restricted with HLA-A24 for patients with completely resected non-small cell lung cancer. randomized phase II trialnon-small cell lung cancerJPRN-UMIN000009380Fukushima Medical University60